149 related articles for article (PubMed ID: 35026631)
1. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs.
Kumar Kushwaha P; Saurabh Srivastava K; Kumari N; Kumar R; Mitra D; Sharon A
Bioorg Med Chem; 2022 Feb; 56():116612. PubMed ID: 35026631
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity.
Trivedi J; Parveen A; Rozy F; Mitra A; Bal C; Mitra D; Sharon A
Eur J Med Chem; 2019 Dec; 183():111699. PubMed ID: 31561045
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, crystal structure and anti-HIV activity of 2-adamantyl/adamantylmethyl-5-aryl-1,3,4-oxadiazoles.
Khan MU; Akhtar T; Al-Masoudi NA; Stoeckli-Evans H; Hameed S
Med Chem; 2012 Nov; 8(6):1190-7. PubMed ID: 22741800
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues.
El-Sayed WA; El-Essawy FA; Ali OM; Nasr BS; Abdalla MM; Abdel-Rahman AA
Z Naturforsch C J Biosci; 2009; 64(11-12):773-8. PubMed ID: 20158144
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Yoon YK; Wei AC; Pandian S; Samy JG; De Clercq E; Pannecouque C
Acta Pol Pharm; 2011; 68(3):343-8. PubMed ID: 21648188
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of C-2 and C-3 substituted quinolines and their evaluation as anti-HIV-1 agents.
Shah P; Naik D; Jariwala N; Bhadane D; Kumar S; Kulkarni S; Bhutani KK; Singh IP
Bioorg Chem; 2018 Oct; 80():591-601. PubMed ID: 30036815
[TBL] [Abstract][Full Text] [Related]
7. Microwave-Assisted Expeditious Synthesis of 2-Alkyl-2-(
Che Z; Tian Y; Liu S; Jiang J; Hu M; Chen G
Molecules; 2018 Nov; 23(11):. PubMed ID: 30423803
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.
Wang Z; Wang M; Yao X; Li Y; Qiao W; Geng Y; Liu Y; Wang Q
Eur J Med Chem; 2012 Apr; 50():361-9. PubMed ID: 22369862
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted combinatorial synthesis of 2-alkyl-2-(N-arylsulfonylindol- 3-yl)-3-N-Acyl-5-Aryl-1,3,4-oxadiazolines as anti-HIV-1 agents.
Che ZP; Huang N; Yu X; Yang LM; Ran JQ; Zhi X; Xu H; Zheng YT
Comb Chem High Throughput Screen; 2013 Jun; 16(5):400-7. PubMed ID: 23176059
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones.
El-Emam AA; Al-Deeb OA; Al-Omar M; Lehmann J
Bioorg Med Chem; 2004 Oct; 12(19):5107-13. PubMed ID: 15351394
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.
Jadhav RD; Kadam KS; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Potdar N; Enose AA; Vishwakarma RA; Sivaramakrishnan H; Srinivasan S; Nemmani KV; Gupte A; Gangopadhyay AK; Sharma R
Eur J Med Chem; 2012 Aug; 54():324-42. PubMed ID: 22683241
[TBL] [Abstract][Full Text] [Related]
12. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies of HIV-1 virion infectivity factor (Vif) inhibitors that block viral replication.
Ali A; Wang J; Nathans RS; Cao H; Sharova N; Stevenson M; Rana TM
ChemMedChem; 2012 Jul; 7(7):1217-29. PubMed ID: 22555953
[TBL] [Abstract][Full Text] [Related]
14. From docking false-positive to active anti-HIV agent.
Barreiro G; Kim JT; Guimarães CR; Bailey CM; Domaoal RA; Wang L; Anderson KS; Jorgensen WL
J Med Chem; 2007 Nov; 50(22):5324-9. PubMed ID: 17918923
[TBL] [Abstract][Full Text] [Related]
15. Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein.
Zentner I; Sierra LJ; Fraser AK; Maciunas L; Mankowski MK; Vinnik A; Fedichev P; Ptak RG; Martín-García J; Cocklin S
ChemMedChem; 2013 Mar; 8(3):426-32. PubMed ID: 23361947
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors.
Ciurea A; Fossey C; Gavriliu D; Delbederi Z; Sugeac E; Laduree D; Schmidt S; Laumond G; Aubertin AM
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):511-9. PubMed ID: 15662955
[TBL] [Abstract][Full Text] [Related]
18. 1,2,3-Triazoles as Amide Bioisosteres: Discovery of a New Class of Potent HIV-1 Vif Antagonists.
Mohammed I; Kummetha IR; Singh G; Sharova N; Lichinchi G; Dang J; Stevenson M; Rana TM
J Med Chem; 2016 Aug; 59(16):7677-82. PubMed ID: 27509004
[TBL] [Abstract][Full Text] [Related]
19. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
Bioorg Med Chem Lett; 2009 Mar; 19(6):1802-6. PubMed ID: 19217781
[TBL] [Abstract][Full Text] [Related]
20. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
